Introduction: Diabetes mellitus (DM) results from relative deficiency or reduced effectiveness of endogenous insulin leading to both micro-vascular and macro-vascular complications. Treatment goal is intensive therapy as early as possible in patients with both type-1 and type-2 diabetes to bring the HbA1c to less than 7%. Occurrence of hypoglycemia in a diabetic patient is a common side effect of treatment. This study was aimed to find the causes of Hypoglycemia in diabetes patients. Methods: It was hospital based cross-sectional observational study on admitted diabetes patients with other co-morbid conditions who were on either oral hypoglycemic agents (OHA) or Insulin. Cause of hypoglycemia was elicited by history taking and analysis. Results: Out of 36 diabetics included in this study, seven had severe hypoglycemia, 22 had moderate to mild hypoglycemia. Most of them had various comorbidities. The causes of hypoglycemic episodes were varied. Conclusion:
INTRODUCTION
The risk of hypoglycemia increases with a b s o l u t e / r e l a t i v e i n s u l i n e x c e s s a n d compromised glucose regulation 5. In earlier stages of type-2 diabetes when glucose counter-regulatory responses are still functional, hypoglycemia is less common than in type-1 diabetic patients. Since progressive B-cell failure is a key pathophysiological feature of type-2 diabetes, the characteristics of disease and frequency of hypoglycemic episodes eventually approach that of type-1 diabetes 6 . Hypoglycemia begets hypoglycemia 7 and overtime worsens to severe hypoglycemia, nocturnal hypoglycemia and arrhythmias 8. Occurrence of hypoglycemia is associated with potentially serious physical and psychological consequences.
This study was aimed to find the causes of hypoglycemia in admitted patients and to prepare the team for early recognition and prompt management of hypoglycemia at our centre. All the blood samples were collected by the nursing staff at the time of clinical/incidental hypoglycemia using glucometer that was further confirmed by biochemistry.
METHODS

RESULTS
Out of the 36 Patients analyzed, 24 were male and 12 were female, ranging from 35 to 91 years of age (table 1). Thirty of them had type-2 DM and 6 had type 1 DM. Most of them
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Original Article Hypoglycemia in Diabetes Mellitus; KC I and health care team should be vigilant in d e t e c t i n g , t r e a t i n g a n d p r e v e n t i n g hypoglycemia while treating diabetic patients.
Certain oral hypoglycemic agents like Sulphonylureas (Glyburide and Metformin) are considered nasty in hypoglycemic patient and significantly dangerous to the developing neuroglycopenia especially in serious patients w i t h c r i t i c a l i l l n e s s a n d o r g a n dysfunction. Recent Indian studies show that only 20.4% of diabetes care physicians set HbA1c of less than 7% as target for their patients 9 and only 19.7% of patients achieve this value 10 . This clinical criteria has often been attributed to presence or fear of hypoglycemia, both among physicians and 
